PLASMATECH BIOPHARMACEUTICALS INC
PLASMATECH BIOPHARMACEUTICALS INC (PTBI) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 27 transactions totaling $2.4M, demonstrating a bullish sentiment with $2.4M in net insider flow. The most recent transaction on May 11, 2015 involved a transaction of 375,000 shares valued at $2.8M.
PTBI Insider Activity Summary
Who Is Buying PTBI Stock?
No significant insider buying has been recorded for PTBI in the recent period.
Who Is Selling PTBI Stock?
No significant insider selling has been recorded for PTBI in the recent period.
Is PLASMATECH BIOPHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PTBI is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PTBI Frequently Asked Questions
Understanding PTBI Insider Activity
Insider trading at PLASMATECH BIOPHARMACEUTICALS INC (PTBI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading PTBI stock, having executed 27 transactions in the past 90 days. The most active insider is Steven H. Rouhandeh (Executive), who has made 10 transactions totaling $56.3M.
Related Tools
Track PLASMATECH BIOPHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at PTBI file new Form 4 transactions